Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 71 - 80 of 120 for mindray. (0.09 seconds)

The Mega-Drug Development Program will invest up to $10...
China CRO Tigermed Consulting...
Hutchison MediPharma Limited sold an option on its...
WuXi PharmaTech (药明康德) reported a 5%...
Xian-Janssen launched Dacogen, a myelodysplastic syndrome...
Cheezheng Tibetan Medicine was approved to IPO on the...
Earnings season has now arrived, and China life science...
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
The world of China life science is...
IMS Health predicts China’s drug market will see a...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here